(1)
Second Line Drugs Resistant Mycobacterium Tuberculosis in Multi-Drug Resistant Tuberculosis Patients. J. Inst. Sci. Tech. 2018, 22 (2), 168-174. https://doi.org/10.3126/jist.v22i2.19609.